SYN-020

· Theriva Biologics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYN-020, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of SYN-020 [Phase 1]